Sheppard Pratt Health System
22
0
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.2%
4 terminated/withdrawn out of 22 trials
73.3%
-13.2% vs industry average
0%
0 trials in Phase 3/4
64%
7 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Coaching Teachers in Bullying Detection and Intervention
Role: collaborator
The R-CITY Project: A Collaborative Intervention With Teachers and Youth
Role: collaborator
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Role: lead
Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness
Role: collaborator
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Role: lead
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Role: lead
Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression
Role: lead
The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Role: lead
Retrospective TMS Therapy for Adults With MDD
Role: collaborator
An Open Label Trial of TMS Therapy for Bipolar Depression
Role: lead
Sulforaphane to Reduce Symptoms of Schizophrenia
Role: lead
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
Role: collaborator
Development of a Scalable Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness
Role: collaborator
Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
Role: lead
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Role: collaborator
Probiotics to Prevent Relapse After Hospitalization for Mania
Role: lead
Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia
Role: lead
A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury
Role: lead
Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
Role: lead
Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD
Role: lead